1,483
Views
9
CrossRef citations to date
0
Altmetric
Regular Section: Motor Speech / Voice

Group therapy for maintenance of speech in parkinson’s disease following LSVT LOUD: a pilot study

ORCID Icon, & ORCID Icon
Pages 105-116 | Received 25 Aug 2016, Accepted 21 May 2017, Published online: 31 May 2017

References

  • Adams, S. G., Dykstra, A., Jenkins, M., & Jog, M. (2008). Speech-to-noise levels and conversational intelligibility in hypophonia and Parkinson's disease. Journal of Medical Speech-language Pathology, 16(4), 165–172.
  • Block, S., & Killen, D. (1996). Speech rates of Australian English-speaking children and adults. Australian Journal of Human Communication Disorders, 24(1), 39–44.
  • Bose, A., McHugh, T., Schollenberger, H., & Buchanan, L. (2009). Measuring quality of life in aphasia: Results from two scales. Aphasiology, 23(7-8), 797–808. doi: 10.1080/02687030802593189
  • Bunton, K., & Keintz, C. K. (2008). The use of a dual-task paradigm for assessing speech intelligibility in clients with Parkinson disease. Journal of Medical Speech-language Pathology, 16(3), 141–155.
  • Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159. doi: 10.1037/0033-2909.112.1.155
  • Darley, F. L., Aronson, A. E., & Brown, J. R. (1969). Clusters of deviant speech dimensions in the dysarthrias. Journal of Speech Language and Hearing Research, 12, 462–496. doi: 10.1044/jshr.1203.462
  • de Angelis, E. C., Mourao, L. F., Ferraz, H. B., Behlau, M. S., Pontes, P. A. L., & Andrade, L. A. F. (1997). Effect of voice rehabilitation on oral communication of Parkinson’s disease patients. Acta Neurologica Scandinavica, 96(4), 199–205. doi: 10.1111/j.1600-0404.1997.tb00269.x
  • Deane, K. H., Whurr, R., Playford, E. D., Ben-Shlomo, Y., & Clarke, C. E. (2001). Speech and language therapy versus placebo or no intervention for dysarthria in Parkinson’s disease. Cochrane Database of Systematic Reviews, CD002812. doi: 10.1002/14651858.CD002812
  • Durlak, J. A. (2009). How to select, calculate, and interpret effect sizes. Journal of Pediatric Psychology, 34(9), 917–928. doi: 10.1093/jpepsy/jsp004
  • Edwards, A. (2014). Maintenance of speech in Parkinson’s disease: The impact of group therapy. (MPhil). The University of Queensland, Brisbane. Retrieved July 4, 2016, from http://espace.library.uq.edu.au/view/UQ:345399
  • Fairbanks, G. (1960). Voice and articulation drill book (2nd ed.). New York: Harper and Row.
  • Fleiss, J. L. (2004). Statistical methods for rates and proportions (3rd ed.). Hoboken, NJ: Wiley-Blackwell.
  • Fox, C. M., Ebersbach, G., Ramig, L. O., & Sapir, S. (2012). LSVT LOUD and LSVT BIG: Behavioral treatment programs for speech and body movement in Parkinson disease. Parkinson’s Disease, 2012, 1–2. doi: 10.1155/2012/391946
  • Fox, C. M., Ramig, L., Ciucci, M., Sapir, S., McFarland, D., & Farley, B. (2006). The science and practice of LSVT/LOUD: Neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders. Seminars in Speech and Language, 27(4), 283–299. doi: 10.1055/s-2006-955118
  • Fox, C. M., & Ramig, L. O. (1997). Vocal sound pressure level and self-perception of speech and voice in men and women with idiopathic Parkinson disease. American Journal of Speech-language Pathology, 6(2), 85–94. doi: 10.1044/1058-0360.0602.85
  • Halpern, A. E., Ramig, L. O., Matos, C. E. C., Petska-Cable, J. A., Spielman, J. L., Pogoda, J. M., … McFarland, D. H. (2012). Innovative technology for the assisted delivery of intensive voice treatment (LSVT® LOUD) for Parkinson disease. American Journal of Speech-language Pathology, 21(4), 354–367. doi: 10.1044/1058-0360(2012/11-0125)
  • Higginson, C. I., King, D. S., Levine, D., Wheelock, V. L., Khamphay, N. O., & Sigvardt, K. A. (2003). The relationship between executive function and verbal memory in Parkinson’s disease. Brain and Cognition, 52(3), 343–352. doi: 10.1016/S0278-2626(03)00180-5
  • Hirsch, O., Keller, H., Albohn-Kühne, C., Krones, T., & Donner-Banzhoff, N. (2011). Pitfalls in the statistical examination and interpretation of the correspondence between physician and patient satisfaction ratings and their relevance for shared decision making research. BMC Medical Research Methodology, 11, 71. doi: 10.1186/1471-2288-11-71
  • Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17(5), 427–427. doi: 10.1212/WNL.17.5.427
  • Holland, A. L. (1998). Functional outcome assessment of aphasia following left hemisphere stroke. Seminars in Speech and Language, 19(3), 249–260. doi: 10.1055/s-2008-1064048
  • IBM. (2012). IBM SPSS statistics for Windows version 21.0. [Software]. Armonk, NY: Author.
  • Kent, R. D., Kent, J. F., & Rosenbek, J. C. (1987). Maximum performance tests of speech production. Journal of Speech and Hearing Disorders, 52(4), 367–387. doi: 10.1044/jshd.5204.367
  • Lazarus, J. P., Vibha, D., Handa, K. K., Singh, S., Goyal, V., Srivastava, T., … Behari, M. (2012). A study of voice profiles and acoustic signs in patients with Parkinson’s disease in North India. Journal of Clinical Neuroscience, 19(8), 1125–1129. doi: 10.1016/j.jocn.2011.10.013
  • Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., … Emre, M. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement disorder society task force guidelines. Movement Disorders, 27(3), 349–356. doi: 10.1002/mds.24893
  • Lomas, J., Bester, S., Elbard, H., Finlayson, A., & Zoghaib, C. (1989). The communicative effectiveness index: Development and psychometric evaluation of a functional communication measure for adult aphasia. The Journal of Speech and Hearing Disorders, 54(1), 113–124. doi: 10.1044/jshd.5401.113
  • Manor, Y., Posen, J., Amir, O., Dori, N., & Giladi, N. (2005). A group intervention model for speech and communication skills in patients with Parkinson’s disease: Initial observations. Communication Disorders Quarterly, 26(2), 94–101. doi: 10.1177/15257401050260020801
  • Martel Sauvageau, V., Roy, J.-P., Langlois, M., & Macoir, J. (2015). Impact of the LSVT on vowel articulation and coarticulation in Parkinsons disease. Clinical Linguistics & Phonetics, 29(6), 424–440. doi: 10.3109/02699206.2015.1012301
  • McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1(1), 30–46. doi: 10.1037/1082-989X.1.1.30
  • Miller, N. (2012). Speech, voice and language in Parkinson’s disease: Changes and interventions. Neurodegenerative Disease Management, 2(3), 279–289. doi: 10.2217/nmt.12.15
  • Miller, N., Noble, E., Jones, D., Allcock, L., & Burn, D. J. (2008). How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clinical Rehabilitation, 22(1), 14–22. doi: 10.1177/0269215507079096
  • Pagonabarraga, J., & Kulisevsky, J. (2012). Cognitive impairment and dementia in Parkinson’s disease. Neurobiology of Disease, 46(3), 590–596. doi: 10.1016/j.nbd.2012.03.029
  • Paul, D. R., Frattali, C. M., Holland, A. L., Thompson, C. K., Caperton, C. J., & Slater, S. C. (2004). Quality of communication life scale (ASHA QCL). Rockville, MD: American Speech-Language-Hearing Association.
  • Plowman-Prine, E. K., Okun, M. S., Sapienza, C. M., Shrivastav, R., Fernandez, H. H., Foote, K. D., … Rosenbek, J. C. (2009). Perceptual characteristics of parkinsonian speech: A comparison of the pharmacological effects of levodopa across speech and non-speech motor systems. NeuroRehabilitation, 24, 131–144.
  • Ramig, L. O. (2001). Intensive voice treatment (LSVT) for patients with Parkinson’s disease: A 2 year follow up. Journal of Neurology, Neurosurgery and Psychiatry, 71(4), 493–498. doi: 10.1136/jnnp.71.4.493
  • Ramig, L. O., Countryman, S., O'Brien, C., Hoehn, M., & Thompson, L. (1996). Intensive speech treatment for patients with Parkinson’s disease: Short-and long-term comparison of two techniques. Neurology, 47(6), 1496–1504. doi: 10.1212/WNL.47.6.1496
  • Ramig, L. O., Countryman, S., Thompson, L. L., & Horii, Y. (1995). Comparison of two forms of intensive speech treatment for Parkinson disease. Journal of Speech Language and Hearing Research, 38(6), 1232–1251. doi: 10.1044/jshr.3806.1232
  • Ramig, L. O., Fox, C., Mahler, L., & Halpern, A. (2007). LSVT Loud® training and certification workshop. Tuscan, AZ: LSVT Global.
  • Ramig, L. O., Levy, E. S., Fox, C. M., Halpern, A., Spielman, J., Moya-Gale, G., & Goudarzi, A. (2015). Impact of LSVT LOUD and LSVT ARTIC on speech intelligibility in Parkinson’s disease. Movement Disorders, 30, S112–S113.
  • Ramig, L. O., Sapir, S., Fox, C. M., & Countryman, S. (2001). Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson’s disease: A comparison with untreated patients and normal age-matched controls. Movement Disorders, 16(1), 79–83. doi: 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H
  • Robertson, D. (2006). Maintaining the art of conversation in Parkinson’s disease. Age and Ageing, 35(3), 211–211. doi: 10.1093/ageing/afj088
  • Robertson, R. J., & Thomson, F. (1984). Speech therapy in Parkinson's disease: A study of the efficacy and long term effects of intensive treatment. International Journal of Language and Communication Disorders, 19, 213–224. doi: 10.3109/13682828409029837
  • Robey, R. R. (2004). A five-phase model for clinical-outcome research. Journal of Communication Disorders, 37(5), 401–411. doi: 10.1016/j.jcomdis.2004.04.003
  • Sapir, S., Ramig, L., Fox, C., & Spielman, J. (2007). Impact of intensive loud phonation training (LSVT/LOUD) on vowel articulation in dysarthric individuals with idiopathic Parkinson’s disease: Acoustic evidence. European Journal of Neurology, 14, 12. doi: 10.1111/j.1468-1331.2006.01518.x
  • Sapir, S., Ramig, L. O., Hoyt, P., Countryman, S., O’Brien, C., & Hoehn, M. (2002). Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson’s disease: A comparison with an alternative speech treatment. Folia Phoniatrica et Logopaedica, 54(6), 296–303. doi: 10.1159/000066148
  • Sarno, M. T. (1968). Speech impairment in Parkinson’s disease. Archives of Physical Medicine and Rehabilitation, 49(5), 269–275.
  • Searl, J., Wilson, K., Haring, K., Dietsch, A., Lyons, K., & Pahwa, R. (2011). Feasibility of group voice therapy for individuals with Parkinson’s disease. Journal of Communication Disorders, 44(6), 719–732. doi: 10.1016/j.jcomdis.2011.05.001
  • Sewall, G. K., Jiang, J., & Ford, C. N. (2006). Clinical evaluation of Parkinson’s-related dysphonia. The Laryngoscope, 116(10), 1740–1744. doi: 10.1097/01.mlg.0000232537.58310.22
  • Shepperd, J. A., & McNulty, J. K. (2002). The affective consequences of expected and unexpected outcomes. Psychological Science, 13(1), 85–88. doi: 10.1111/1467-9280.00416
  • Smith, M. E., Ramig, L. O., Dromey, C., Perez, K. C., & Samandari, R. (1995). Intensive voice treatment in Parkinson disease: Laryngostroboscopic findings. Journal of Voice, 9(4), 453–459. doi: 10.1016/S0892-1997(05)80210-3
  • Spielman, J. L., Borod, J. C., & Ramig, L. O. (2003). The effects of intensive voice treatment on facial expressiveness in Parkinson disease: Preliminary data. Cognitive and Behavioral Neurology, 16(3), 177–188. doi: 10.1097/00146965-200309000-00005
  • Spielman, J. L., Ramig, L. O., Mahler, L., Halpern, A., & Gavin, W. J. (2007). Effects of an extended version of the Lee Silverman voice treatment on voice and speech in Parkinson’s disease. American Journal of Speech-language Pathology, 16(2), 95–107. doi: 10.1044/1058-0360(2007/014)
  • Suits, B. H. (1998). Physics of music – notes [online]. Michigan Technological University. Retrieved March 1, 2007, from http://www.phy.mtu.edu/~suits/notefreqs.html
  • Sullivan, M., Brune, P., & Beukelman, D. R. (1996). Maintenance of speech changes following group treatment for hypokinetic dysarthria of Parkinson’s disease. In D. A. Robin, K. M. Yorkston, & D. R. Beukelman (Eds.), Disorders of motor speech: Assessment, treatment and clinical characterization (pp. 287–308). Baltimore, MD: Paul H. Brookes.
  • Walshe, M., Peach, R. K., & Miller, N. (2009). Dysarthria impact profile: Development of a scale to measure psychosocial effects. International Journal of Language and Communication Disorders, 44(5), 693–715. doi: 10.1080/13682820802317536
  • Weismer, G. (1984). Articulatory characteristics of parkinsonian dysarthria: Segmental and phrase-level timing, spirantization, and glottal-supraglottal coordination. In M. R. McNeil, J. C. Rosenbek, & A. E. Aronson (Eds.), The dysarthrias: Physiology, acoustics, perception, management (pp. 101–130). San Diego: College Hill.
  • Wenke, R. J. (2008). The short and long term effects of the Lee Silverman Voice Treatment ® in non-progressive Dysarthria (PhD). The University of Queensland, Brisbane.
  • Wight, S., & Miller, N. (2015). Lee silverman voice treatment for people with Parkinson’s: Audit of outcomes in a routine clinic. International Journal of Language and Communication Disorders, 50(2), 215–225. doi: 10.1111/1460-6984.12132

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.